Long-Acting Aripiprazole in the Management of Violence in Treatment Nonadherent Schizophrenia

Prim Care Companion CNS Disord. 2021 Jan 14;23(1):20l02623. doi: 10.4088/PCC.20l02623.

Authors

Tommaso Toffanin^{1

2}, Alessandro Miola², Benedetta Salvati², Francesco Folena Comini², Chiara Pavan², Giorgio Pigato², Fabio Sambataro²

Affiliations

¹ Department of Neuroscience, Psychiatry Unit, University-Hospital of Padova, Via Giustiniani 2, 35128 Padova, Italy. tommaso.toffanin@aopd.veneto.it.
² Department of Neurosciences, Psychiatry Unit, University-Hospital of Padova, Padova, Italy.

PMID: 33445228
DOI: 10.4088/PCC.20l02623

No abstract available

MeSH terms

Antipsychotic Agents* / therapeutic use
Aripiprazole / therapeutic use
Delayed-Action Preparations / therapeutic use
Humans
Schizophrenia* / drug therapy
Violence

Substances

Antipsychotic Agents
Delayed-Action Preparations
Aripiprazole